Interviewer: How important is turnaround time for labs using Choice PharmD? Choice PharmD: Turnaround time is critical. Our average turnaround is about 10 to 15
Interviewer: What differentiates Choice PharmD from other interpretive reporting solutions? Choice PharmD: Every report we generate is reviewed by a clinical pharmacist rather than relying
Interviewer: In simple terms, what is Choice PharmD, and what problem does it solve? Choice PharmD: Choice PharmD is a lab consulting firm that reviews
Interpretive reports (e.g. PharmD reports) of molecular diagnostic tests deliver critical therapeutic guidance by supplementing the results with pathogen explanations, antimicrobial stewardship insights, and evidence-based
Choice PharmD interpretation services help bridge the gap between molecular diagnostics and clinical decision-making. Once PCR technology identifies pathogens and resistance genes, a clinical pharmacist
Molecular diagnostics today can identify bacteria and resistance genes with remarkable precision. But precise data alone doesn’t always equal clear treatment decisions. Too often, clinicians
